Trade

with

Prothena Corp PLC
(NASDAQ: PRTA)
AdChoices
18.99
-0.82
-4.14%
After Hours :
18.99
0.00
0.00%

Open

20.00

Previous Close

19.81

Volume (Avg)

138.78k (253.48k)

Day's Range

18.96-20.18

52Wk Range

16.71-49.24

Market Cap.

542.32M

Dividend Rate ( Yield )

-

Beta

-

Shares Outstanding

27.38M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Biotechnology
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 676.00k

    • Net Income

    • -41.00M

    • Market Cap.

    • 542.32M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -3.36

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • -

    • Forward P/E

    • -8.50

    • Price/Sales

    • 8.82

    • Price/Book Value

    • 1.82

    • Price/Cash flow

    • 106.38

      • EBITDA

      • -39.77M

      • Return on Capital %

      • -0.75

      • Return on Equity %

      • -0.79

      • Return on Assets %

      • -0.75

      • Book Value/Share

      • 10.90

      • Shares Outstanding

      • 27.38M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Buy
        • 1 Year Price Target

        • 43.00

        • Credit Rating

        • -

        • Analysts

        • 3

        • EPS Estimate

        • -2.32

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 8,954.50

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • -

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • -

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 100.00

            • 82.75

            • Pre-Tax Margin

            • -1.82

            • 39.38

            • Net Profit Margin

            • -3.36

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • -

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.76

              • Current Ratio

              • 27.14

              • 2.92

              • Quick Ratio

              • 27.00

              • 2.35

              • Interest Coverage

              • -

              • 38.02

              • Leverage Ratio

              • 1.04

              • 2.21

              • Book Value/Share

              • 10.90

              • 4.75

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -256.41

                • 277.78

                • P/E Ratio 5-Year High

                • -637.77

                • 634.30

                • P/E Ratio 5-Year Low

                • -73.05

                • 124.82

                • Price/Sales Ratio

                • 8.82

                • 9.35

                • Price/Book Value

                • 1.82

                • 8.50

                • Price/Cash Flow Ratio

                • 106.38

                • 50.25

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -0.79

                        (-)

                      • 37.63

                        (27.20)

                      • Return on Assets %

                        (5-Year Average)

                      • -0.75

                        (-)

                      • 17.22

                        (13.81)

                      • Return on Capital %

                        (5-Year Average)

                      • -0.79

                        (-)

                      • 21.78

                        (17.31)

                      • Income/Employee

                      • -

                      • 117.08k

                      • Inventory Turnover

                      • -

                      • 1.48

                      • Asset Turnover

                      • 0.22

                      • 0.55

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -40.43M
                      Operating Margin
                      -5,980.33
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      106.38
                      Ownership

                      Institutional Ownership

                      94.74%

                      Top 10 Institutions

                      61.84%

                      Mutual Fund Ownership

                      52.39%

                      Float

                      77.08%

                      5% / Insider Ownership

                      0.07%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • CF Woodford Equity Income

                      •  

                        2,222,222

                      • 0.00

                      • 7.99

                      • Fidelity® Growth Company Fund

                      •  

                        1,946,071

                      • 19.77

                      • 7.11

                      • Vanguard Health Care Fund

                      •  

                        1,662,794

                      • 25.26

                      • 6.24

                      • T. Rowe Price Health Sciences Fund

                      •  

                        1,229,200

                      • 35.93

                      • 4.61

                      • SPDR® S&P Biotech ETF

                      •  

                        757,251

                      • 0.00

                      • 2.47

                      • Prudential Jennison Health Sciences

                      •  

                        472,125

                      • 0.00

                      • 1.72

                      • Fidelity® Series Growth Company Fund

                      •  

                        465,100

                      • 18.71

                      • 1.70

                      • Fidelity® Select Biotechnology Portfolio

                      •  

                        461,318

                      • 20.41

                      • 1.69

                      • iShares Russell 2000 (AU)

                      •  

                        412,784

                      • -0.90

                      • 1.35

                      • CREF Stock

                      •  

                        398,901

                      • 0.00

                      • 1.46

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • T. Rowe Price Associates, Inc.

                      •  

                        2,935,996

                      • +30.18%

                      • 11.01

                      • Fidelity Management and Research Company

                      •  

                        2,753,292

                      • -29.07%

                      • 10.33

                      • Wellington Management Company, LLP

                      •  

                        2,364,196

                      • +45.35%

                      • 8.87

                      • Woodford Investment Management LLP

                      •  

                        2,222,222

                      • 0.00%

                      • 7.99

                      • Merrill Lynch & Co Inc

                      •  

                        1,655,955

                      • +26,256.12%

                      • 6.21

                      • Westfield Capital Management Company, LP

                      •  

                        1,061,820

                      • +107.01%

                      • 3.98

                      • Capital World Investors

                      •  

                        1,011,479

                      • +22.36%

                      • 3.79

                      • State Street Corp

                      •  

                        899,369

                      • +311.61%

                      • 3.37

                      • Jennison Associates LLC

                      •  

                        874,794

                      • +13.50%

                      • 3.28

                      • BlackRock Fund Advisors

                      •  

                        802,754

                      • +20.75%

                      • 3.01

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Biotechnology

                      Type

                      -

                      Style

                      Small Core

                      Prothena Corporation PLC is a biotechnology company. It discovers and develops novel antibodies for the potential treatment of a broad range of diseases that involve protein misfolding or cell adhesion.

                      Key People

                      Dr. Dale Schenk,PhD

                      CEO/Director/President

                      Dr. Lars Ekman M.D.,PhD

                      Chairman of the Board/Director

                      Tran B. Nguyen

                      CFO

                      Richard T. Collier

                      Director

                      Dr. Dennis J Selkoe M.D.

                      Director

                      • Prothena Corp PLC

                      • 650 Gateway Boulevard

                      • South San Francisco, CA 94080

                      • IRL.Map

                      • Phone: +1 650 837-8550

                      • Fax: -

                      • prothena.com

                      Incorporated

                      2012

                      Employees

                      39

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: